Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration

Autor: Reinhold Schmidt, Werner Seeger, Jochen Börgermann, Alexander Olk, Andreas Günther, Fred H. Splittgerber, Markus Balser, Philipp Markart, Ivar Friedrich
Rok vydání: 2004
Předmět:
Male
Time Factors
medicine.medical_treatment
Statistics as Topic
Severity of Illness Index
chemistry.chemical_compound
Postoperative Complications
Pulmonary surfactant
Phospholipids
medicine.diagnostic_test
respiratory system
Lipids
medicine.anatomical_structure
Anesthesia
Reperfusion Injury
Female
Cardiology and Cardiovascular Medicine
Bronchoalveolar Lavage Fluid
Lung Transplantation
Pulmonary and Respiratory Medicine
Pulmonary Surfactant-Associated Proteins
Transplantation
Heterologous

Lung injury
Models
Biological

Dogs
Phosphatidylcholine
Bronchoscopy
medicine
Lung transplantation
Animals
Surface Tension
Lung
Dose-Response Relationship
Drug

business.industry
Proteins
Pulmonary Surfactants
medicine.disease
respiratory tract diseases
Transplantation
Pulmonary Alveoli
Disease Models
Animal

Bronchoalveolar lavage
chemistry
Surgery
business
Apoproteins
Reperfusion injury
Biomarkers
Zdroj: The Journal of thoracic and cardiovascular surgery. 127(2)
ISSN: 0022-5223
Popis: Objective Disturbances of the alveolar surfactant system have been implicated in the pathogenesis of reperfusion injury. The aim of this study was to evaluate the influence of exogenous surfactant administration on surfactant properties in a model of single lung transplantation. Methods We performed heterologous, left lung transplantation (+4°C ischemia; 24 hours, Euro-Collins solution) in 6 foxhounds (untreated) and in 6 animals that received calf lung surfactant extract (Alveofact) prior to explantation (only donor lung; 50 mg/kg body weight) and immediately after onset of reperfusion (both lungs, 200 mg/kg body weight). Separate but synchronized ventilation of each lung was performed, in a volume-controlled, pressure-limited mode, with animals in prone position. Bronchoalveolar lavage fluids were collected in pretransplantation lungs (control), after 24 hours of ischemia prior to transplantation (0 hours) and 6 and 12 hours after reperfusion in both the grafts and the recipient native lungs. Results Ischemic storage per se did not provoke any changes of the surfactant system; however, severe alterations occurred within 6 hours of reperfusion, resulting in a severe loss of surface activity, including a decrease in the percentage of the large surfactant aggregate fraction, reduction of the surfactant apoproteins SP-B and SP-C, the dipalmitoyl molecular species of phosphatidylcholine and phosphatidylglycerol within the large surfactant aggregate fraction. These abnormalities were restricted to the graft, with virtually normal surfactant function and composition being found in the recipient native lung. Surfactant administration fully normalized the biochemical and largely improved the biophysical surfactant properties, alongside maintenance of lung gas exchange properties. Conclusions Severe surfactant abnormalities occur exclusively in the graft when performing separate, synchronized ventilation of each lung to attenuate ventilator-induced lung injury. Bronchoscopic surfactant administration provides protection against these abnormalities and may be a therapeutic strategy in lung transplantation.
Databáze: OpenAIRE